{"book_asymmetry_distribution":[],"carrier_id":null,"cer_runtime_export":{"decision_count":0,"decisions":[],"schema":"velaru-cer-export-v1","transfer_aligned_count":0,"transfer_aligned_ratio":null},"cross_platform_entries":[],"disclaimer":"Anonymized behavioral signals \u2014 not filed loss development. For actuarial correlation study with carrier loss triangles.","entry_count":0,"generated_at":"2026-08-15T05:35:06.852010Z","insurance_lines":["Biotech E&O","Product liability"],"schema_version":"velaru-galactic-actuarial-1.0","tam_note":"Synthetic biology market $80B+ \u00b7 DNA synthesis screening mandatory","vertical_key":"synthetic_biology","vertical_name":"Synthetic Biology / Biosecurity"}
